Focus: Infection Control

Pan-resistant bacteria now considered worldwide threat

Woman in Reno, Nev., killed by superbug after visiting India


While pan-resistant bacteria are very rare, superbugs resistant to antibiotics still remain a global concern, according to an article on the Inquisitr website. A woman in Reno, Nev., was recently killed by a superbug after visiting India.

A report predicted 10 million people per year would die from antibiotic-resistant infections by the year 2050 if nothing were done to combat the threat.

The Centers for Disease Control and Prevention said this most recent infection case should serve as a reminder for health practitioners to ask incoming patients about any travel outside the country.

In addition, extra infection control measures should be taken, including quarantining anyone who may be sick with a superbug.

Read the article.

 



January 20, 2017


Topic Area: Infection Control


Recent Posts

How Architects Shape the Future of Healthcare Facilities

Healthcare architecture is more than just designing and building hospitals.


UNC Health, Duke Health Form Partnership for Stand-alone Children's Hospital

The partners plan to break ground together on the new NC Children’s campus by 2027.


Sarasota Memorial Hospital Plans to Build New Facility in North Port

The six-story, 100-bed hospital is slated to open in fall of 2028.


CMMS, Data and the Path to Compliance

Taking control of healthcare facilities data in CMMS enables managers to use it to ensure the efficient operation and maintenance of their assets.


Healthcare is a Major Ransomware Target

Healthcare is the third-most-targeted sector, according to the report.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.